Neuralink rival Paradromics completes its first brain implant in a human patient

Neurotech Breakthrough: Paradromics successfully implanted its brain-computer interface (BCI) in a human patient during epilepsy surgery at the University of Michigan, aiming to assist individuals with motor neuron disorders by translating brain signals into commands for electronic devices.

Future Plans and Funding: The company plans to initiate a clinical trial later this year, pending FDA approval, after raising $140 million from Saudi Arabia’s Neom Investment Fund, focusing on long-term safety and potential applications for speech restoration and mental health conditions.